Remodeling of the bone is under the control of two kinds of cells osteoblasts and osteoclasts. The process of remodeling begins by migration of osteoclasts, followed by resorption of bone by these cells. This is followed by a reversal phase characterized by the apoptosis of the osteoclasts and a final phase of bone formation by newly formed osteoblasts. The critical initial step in this process-the development of osteoclasts-is under the control of preosteoblastic/stromal cells; this ensures that the bone resorption and formation processes will be tightly coupled, allowing a wave of bone formation to follow each cycle of bone resorption thus maintaining skeletal integrity. In adults, as much as 18% of the total bone calcium is removed and deposited every year. The extracellular component of the bone consists of an organic matrix and an inorganic reservoir of largely calcium and phosphorous. The organic matrix of the bone is produced by osteoblasts and mainly consists of type 1 collagen, which is involved in the formation of new bone. The osteoblasts also produce several noncollagenous proteins such as osteocalcin and alkaline phosphatase, which are increased in high-turnover bone conditions. The factors implicated in the growth and differentiation of osteoblasts include interleukin 1, interleukin 6, tumor necrosis factor-, transforming growth factor, fibroblast growth factor, bone morphogenic proteins (BMP), insulinlike growth factor (IGF) and IGF-binding protein. These factors function in an autocrine manner and may also serve as the mediators of stimulation by parathyroid hormone. Other systemic processes that affect the skeleton include accumulation of 2 microglobulin and steroid-induced or post menopausal osteoporosis. [8]